Advertisement

AIDS and Behavior

, Volume 19, Issue 8, pp 1423–1429 | Cite as

Factors Associated with Missed Psychiatry Visits in an Urban HIV Clinic

  • Christina P. Ho
  • Anne Zinski
  • Susanne A. Fogger
  • Jonathan D. Peters
  • Andrew O. Westfall
  • Michael J. Mugavero
  • Sarah T. Lawrence
  • Christa R. Nevin
  • James L. Raper
  • Michael S. Saag
  • James H. Willig
Original Paper

Abstract

Psychiatric co-management is often required in HIV primary care. While rates and clinical impact of linkage and retention in HIV are well explored, fewer investigations focus specifically on linkage to psychiatry. In this investigation, we evaluate factors associated with linkage to psychiatric services using a retrospective cohort study of HIV-infected patients during a two-year observation period. Descriptive statistics depict patient characteristics, and logistic regression models were fit to evaluate factors associated with failure to establish care at the co-located psychiatry clinic following referral from HIV provider. Of 370 referred, 23 % did not attend a scheduled psychiatry appointment within 6 months of initial referral. In multivariable analysis, Non-white race, younger age, non-suppressed viral load, and increased wait time to appointment (in days) were associated with failure to attend. Further exploration of barriers that contribute to disparate linkage to psychiatric care may inform future interventions to improve HIV outcomes in this population.

Resumen

El co-manejo con psiquiatria se requiere frecuentemente en el cuidado de pacientes con VIH. Mientras se conoce bastante sobre las tasas de vinculacion y retencion en la atencion del VIH, pocos studios se han enfocado en la vinculacion de pacientes en cuidados psiquiatricos. En esta investigación, evaluamos los factores asociados con la vinculación a servicios psiquiátricosde pacientes VIH positivos en un estudio retrospectivo de una cohorte de pacientes durante un periodo de observación de dos años. Se utilizan métodos estadísticos descriptivos para representar las características de los pacientes, y se ajustaron modelos de regresión logística para evaluar los factores asociados con el fracaso en el establecimiento de atención en la clínica de psiquiatría (vinculación) co-ubicada en el recinto de nuestra clínica de VIH siguiendo referimiento por el medico primario. De 370 pacientes referidos, el 23 % no acudieron a la cita programada después de seis meses tras el referimiento inicial. En el análisis multivariable, la raza no blanca, la edad más joven, la carga viral no suprimida, y un major tiempo de espera para la cita (en días) se asociaron con la no asistencia. Exploración adicional de las barreras que contribuyen a no establecer el vinculo inicial con psiquiatría podrá informar futuras intervenciones para mejorar los resultados clínicos en pacientes con VIH.

Keywords

Linkage to care HIV Psychiatry Mental health 

Notes

Acknowledgments

We thank the UAB 1917 HIV/AIDS Clinic Cohort Observational Database project and the UAB Center for AIDS Research. Dr. James H. Willig and Christina Ho take responsibility for the integrity of the data and the accuracy of the data analysis. Data presented in part at the 6th International Conference on HIV Treatment and Prevention Adherence. May 22–24, 2011. Miami, Florida.

References

  1. 1.
    Ances BM, Letendre SL, Alexander T, Ellis RJ. Role of psychiatric medications as adjunct therapy in the treatment of HIV associated neurocognitive disorders. Int Rev Psychiatry. 2008;20(1):89–93. doi: 10.1080/09540260701877670.PubMedCrossRefGoogle Scholar
  2. 2.
    Angelino AF, Treisman GJ. Issues in co-morbid severe mental illnesses in HIV infected individuals. Int Rev Psychiatry. 2008;20(1):95–101. doi: 10.1080/09540260701861989.PubMedCrossRefGoogle Scholar
  3. 3.
    Bhatia R, Hartman C, Kallen MA, Graham J, Giordano TP. Persons newly diagnosed with HIV infection are at high risk for depression and poor linkage to care: results from the Steps Study. AIDS Behav. 2011;15(6):1161–70. doi: 10.1007/s10461-010-9778-9.PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Birger RB, Hallett TB, Sinha A, Grenfell BT, Hodder SL. Modeling the impact of interventions along the HIV continuum of care in Newark, New Jersey. Clin Infect Dis. 2014;58(2):274–84. doi: 10.1093/cid/cit687.PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Blank MB, Himelhoch S, Walkup J, Eisenberg MM. Treatment considerations for HIV-infected individuals with severe mental illness. Curr HIV/AIDS Rep. 2013;10(4):371–9. doi: 10.1007/s11904-013-0179-3.PubMedCrossRefGoogle Scholar
  6. 6.
    Bouhnik AD, Préau M, Vincent E, Carrieri MP, Gallais H, Lepeu G, Gastaut JA, Moatti JP, Spire B, MANIF 2000 Study Group. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy. Antivir Ther. 2005;10(1):53–61.PubMedGoogle Scholar
  7. 7.
    Cohen MS, Smith MK, Muessig KE, Hallett TB, Powers KA, Kashuba AD. Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here? Lancet. 2013;382(9903):1515–24. doi: 10.1016/s0140-6736(13)61998-4.PubMedCrossRefGoogle Scholar
  8. 8.
    Corless IB, Guarino AJ, Nicholas PK, Tyer-Viola L, Kirksey K, Brion J, Dawson Rose C, Eller LS, Rivero-Mendez M, Kemppainen J, Nokes K, Sefcik E, Voss J, Wantland D, Johnson MO, Phillips JC, Webel A, Iipinge S, Portillo C, Chen WT, Maryland M, Hamilton MJ, Reid P, Hickey D, Holzemer WL, Sullivan KM. Mediators of antiretroviral adherence: a multisite international study. AIDS Care. 2013;25(3):364–77. doi: 10.1080/09540121.09542012.09701723.PubMedCentralPubMedGoogle Scholar
  9. 9.
    Hasan A, Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Thibaut F, Möller HJ, World Federation of Societies of Biological Psychiatry (WFSBP) Task Force on Treatment Guidelines for Schizophrenia. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance. World J Biol Psychiatry. 2012;13(5):318–78. doi: 10.3109/15622975.2012.696143.PubMedCrossRefGoogle Scholar
  10. 10.
    Hasan A, Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, WFSBP Task Force on Treatment Guidelines for Schizophrenia. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects. World J Biol Psychiatry. 2013;14(1):2–44. doi: 10.3109/15622975.2012.739708.PubMedCrossRefGoogle Scholar
  11. 11.
    Horberg MA, Silverberg MJ, Hurley LB, Towner WJ, Klein DB, Bersoff-Matcha S, Weinberg WG, Antoniskis D, Mogyoros M, Dodge WT, Dobrinich R, Quesenberry CP, Kovach DA. Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. J Acquir Immune Defic Syndr. 2008;47(3):384–90. doi: 10.1097/QAI.0b013e318160d53e.PubMedCrossRefGoogle Scholar
  12. 12.
    Ironson G, O’Cleirigh C, Fletcher MA, Laurenceau JP, Balbin E, Klimas N, Schneiderman N, Solomon G. Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment. Psychosom Med. 2005;67(6):1013–21. doi: 10.1097/01.psy.0000188569.58998.c8.PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    Israelski DM, Prentiss DE, Lubega S, Balmas G, Garcia P, Muhammad M, Cummings S, Koopman C. Psychiatric co-morbidity in vulnerable populations receiving primary care for HIV/AIDS. AIDS Care. 2007;19(2):220–5. doi: 10.1080/09540120600774230.PubMedCrossRefGoogle Scholar
  14. 14.
    Kelly JA. HIV risk reduction interventions for persons with severe mental illness. Clin Psychol Rev. 1997;17(3):293–309.PubMedCrossRefGoogle Scholar
  15. 15.
    Kozak MS, Mugavero MJ, Ye J, Aban I, Lawrence ST, Nevin CR, Raper JL, McCullumsmith C, Schumacher JE, Crane HM, Kitahata MM, Saag MS, Willig JH. Patient reported outcomes in routine care: advancing data capture for HIV cohort research. Clin Infect Dis. 2012;54(1):141–7. doi: 10.1093/cid/cir727.PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Lacy NL, Paulman A, Reuter MD, Lovejoy B. Why we don’t come: patient perceptions on no-shows. Ann Fam Med. 2004;2(6):541–5. doi: 10.1370/afm.123.PubMedCentralPubMedCrossRefGoogle Scholar
  17. 17.
    Lawrence ST, Willig JH, Crane HM, Ye J, Aban I, Lober W, Nevin CR, Batey DS, Mugavero MJ, McCullumsmith C, Wright C, Kitahata M, Raper JL, Saag MS, Schumacher JE. Routine, self-administered, touch-screen, computer-based suicidal ideation assessment linked to automated response team notification in an HIV primary care setting. Clin Infect Dis. 2010;50(8):1165–73. doi: 10.1086/651420.PubMedCentralPubMedCrossRefGoogle Scholar
  18. 18.
    London AS, Turner BJ, Eggan F, Beckman R, Vitiello B, Morton SC, Orlando M, Bozzette SA, Ortiz-Barron L, Shapiro M. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry. 2001;58(8):721–8.PubMedCrossRefGoogle Scholar
  19. 19.
    McCombe JA, Noorbakhsh F, Buchholz C, Trew M, Power C. NeuroAIDS: a watershed for mental health and nervous system disorders. J Psychiatry Neurosci. 2009;34(2):83–5.PubMedCentralPubMedGoogle Scholar
  20. 20.
    Mitchell AJ, Lord O, Malone D. Differences in the prescribing of medication for physical disorders in individuals with v. without mental illness: meta-analysis. Br J Psychiatry. 2012;201(6):435–43. doi: 10.1192/bjp.bp.111.094532.PubMedCrossRefGoogle Scholar
  21. 21.
    Mugavero MJ, Lin HY, Allison JJ, Willig JH, Chang PW, Marler M, Raper JL, Schumacher JE, Pisu M, Saag MS. Failure to establish HIV care: characterizing the “no show” phenomenon. Clin Infect Dis. 2007;45(1):127–30. doi: 10.1086/518587.PubMedCrossRefGoogle Scholar
  22. 22.
    Mugavero MJ, Hui-Yi L, Willig JH, Westfall AO, Ulett KB, Routman JS, Abroms S, Raper JL, Saag MS, Allison JJ. Missed visits and mortality among patients establishing initial outpatient HIV treatment. Clin Infect Dis. 2009;48(2):248–56. doi: 10.1086/595705.PubMedCentralPubMedCrossRefGoogle Scholar
  23. 23.
    National HIV/AIDS Strategy for the United States. Washington. DC: The White House; 2010.Google Scholar
  24. 24.
    Nevin CR, Ye J, Aban I, Mugavero MJ, Jackson D, Lin HY, Allison J, Raper JL, Saag MS, Willig JH. The role of toxicity-related regimen changes in the development of antiretroviral resistance. AIDS Res Hum Retroviruses. 2011;27(9):957–63. doi: 10.1089/AID.2010.0291.PubMedCentralPubMedCrossRefGoogle Scholar
  25. 25.
    Orlando M, Burnam MA, Beckman R, Morton SC, London AS, Bing EG, Fleishman JA. Re-estimating the prevalence of psychiatric disorders in a nationally representative sample of persons receiving care for HIV: results from the HIV Cost and Services Utilization Study. Int J Methods Psychiatr Res. 2002;11(2):75–82.PubMedCrossRefGoogle Scholar
  26. 26.
    Pecoraro A, Royer-Malvestuto C, Rosenwasser B, Moore K, Howell A, Ma M, Woody GE. Factors contributing to dropping out from and returning to HIV treatment in an inner city primary care HIV clinic in the United States. AIDS Care. 2013. doi: 10.1080/09540121.2013.772273.PubMedGoogle Scholar
  27. 27.
    Pence BW. The impact of mental health and traumatic life experiences on antiretroviral treatment outcomes for people living with HIV/AIDS. J Antimicrob Chemother. 2009;63(4):636–40. doi: 10.1093/jac/dkp006.PubMedCentralPubMedCrossRefGoogle Scholar
  28. 28.
    Pence BW, Miller WC, Gaynes BN, Eron JJ. Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2007;44(2):159–66. doi: 10.1097/QAI.0b013e31802c2f51.PubMedCrossRefGoogle Scholar
  29. 29.
    Reece M. HIV-related mental health care: factors influencing dropout among low-income. HIV-positive individuals. AIDS Care. 2003;15(5):707–16. doi: 10.1080/09540120310001595195.PubMedGoogle Scholar
  30. 30.
    Schumacher JE, McCullumsmith C, Mugavero MJ, Ingle-Pang PE, Raper JL, Willig JH, You Z, Batey DS, Crane H, Lawrence ST, Wright C, Treisman G, Saag MS. Routine depression screening in an HIV clinic cohort identifies patients with complex psychiatric co-morbidities who show significant response to treatment. AIDS Behav. 2013;17(8):2781–91. doi: 10.1007/s10461-012-0342-7.PubMedCrossRefGoogle Scholar
  31. 31.
    Shittu RO, Issa B, Olanrewaju GT, Mahmoud AO, Odeigah LO, Salami AK, Aderibigbe SA. Prevalence and correlates of depressive disorders among people living with HIV/AIDS, in North Central Nigeria. J AIDS Clin Res. 2013. doi: 10.4172/2155-6113.1000251.Google Scholar
  32. 32.
    Springer SA, Dushaj A, Azar MM. The impact of DSM-IV mental disorders on adherence to combination antiretroviral therapy among adult persons living with HIV/AIDS: a systematic review. AIDS Behav. 2012;16(8):2119–43. doi: 10.1007/s10461-012-0212-3.PubMedCentralPubMedCrossRefGoogle Scholar
  33. 33.
    Thompson MA, Mugavero MJ, Amico KR, Cargill VA, Chang LW, Gross R, Orrell C, Altice FL, Bangsberg DR, Bartlett JG, Beckwith CG, Dowshen N, Gordon CM, Horn T, Kumar P, Scott JD, Stirratt MJ, Remien RH, Simoni JM, Nachega JB. Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care Panel. Ann Intern Med. 2012;156(11):817–33.PubMedCentralPubMedCrossRefGoogle Scholar
  34. 34.
    Treisman GJ, Angelino AF, Hutton HE. Psychiatric issues in the management of patients with HIV infection. JAMA. 2001;286(22):2857–64.PubMedCrossRefGoogle Scholar
  35. 35.
    Ulett KB, Willig JH, Lin HY, Routman JS, Abroms S, Allison J, Chatham A, Raper JL, Saag MS, Mugavero MJ. The therapeutic implications of timely linkage and early retention in HIV care. AIDS Patient Care STDS. 2009;23(1):41–9. doi: 10.1089/apc.2008.0132.PubMedCentralPubMedCrossRefGoogle Scholar
  36. 36.
    Weiser SD, Wolfe WR, Bangsberg DR. The HIV epidemic among individuals with mental illness in the United States. Curr HIV/AIDS Rep. 2004;1(4):186–92.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Christina P. Ho
    • 1
  • Anne Zinski
    • 1
  • Susanne A. Fogger
    • 1
  • Jonathan D. Peters
    • 1
  • Andrew O. Westfall
    • 1
  • Michael J. Mugavero
    • 1
  • Sarah T. Lawrence
    • 1
  • Christa R. Nevin
    • 1
  • James L. Raper
    • 1
  • Michael S. Saag
    • 1
  • James H. Willig
    • 1
  1. 1.Department of MedicineUniversity of Alabama at BirminghamBirminghamUSA

Personalised recommendations